PDEX
Pro-Dex, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$54.66-4.74%
Price as of Jul 20, 2026
PDEX profitability
Pro-Dex, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 27.8%
- EBITDA margin
- 26.3%
- EBIT margin
- 14.5%
- Net margin
- 16.1%
- Free cash flow margin
- 9.3%
Returns
- Return on equity
- 26.6%
- Return on assets
- 16.0%
- Return on invested capital
- 16.5%
- Asset turnover
- 1.09x
Cash efficiency
- Cash from operations
- $7.3M
- Cash per share
- $3.44
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.